SI-Bone (SIBN) Stock Forecast & Price Target

Compare

186 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SIBN Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

SI-Bone

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SIBN Stock 12 Month Forecast

Average Price Target

$25.20

▲(62.79% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for SI-Bone in the last 3 months. The average price target is $25.20 with a high forecast of $28.00 and a low forecast of $21.00. The average price target represents a 62.79% change from the last price of $15.48.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","29":"$29","16.25":"$16.25","20.5":"$20.5","24.75":"$24.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$21.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.25,20.5,24.75,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.37,17.264615384615386,18.15923076923077,19.053846153846155,19.94846153846154,20.843076923076925,21.737692307692306,22.63230769230769,23.526923076923076,24.42153846153846,25.316153846153846,26.21076923076923,27.105384615384615,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.37,17.04923076923077,17.728461538461538,18.407692307692308,19.086923076923078,19.76615384615385,20.445384615384615,21.124615384615385,21.803846153846152,22.483076923076922,23.162307692307692,23.841538461538462,24.52076923076923,{"y":25.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.37,16.726153846153846,17.082307692307694,17.43846153846154,17.794615384615387,18.15076923076923,18.506923076923076,18.863076923076925,19.21923076923077,19.575384615384614,19.931538461538462,20.287692307692307,20.643846153846155,{"y":21,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.76,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.04,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.68,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.86,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.39,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.45,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.27,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.83,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.87,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.37,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$28.00

Average Price Target$25.20

Lowest Price Target$21.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Mathew Blackman

TD Cowen

$21

Buy

35.66%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Molecular Partners (NASDAQ: MOLN) and SI-Bone (NASDAQ: SIBN)

Richard Newitter

Truist Financial

―

Buy

―

Reiterated

01/13/26

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (NASDAQ: BLTE), Sight Sciences (NASDAQ: SGHT) and SI-Bone (NASDAQ: SIBN)

William Plovanic

Canaccord Genuity

$27

Buy

74.42%

Upside

Reiterated

01/13/26

Canaccord Genuity Reaffirms Their Buy Rating on SI-Bone (SIBN)

David Saxon

Needham

$27

Buy

74.42%

Upside

Reiterated

01/12/26

Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY), SI-Bone (NASDAQ: SIBN) and Guardant Health (NASDAQ: GH)

Rong Li

Jefferies

Not Ranked

Jefferies

$28

Buy

80.88%

Upside

Reiterated

01/09/26

Jefferies Remains a Buy on SI-Bone (SIBN)

Patrick Wood

Morgan Stanley

$20→$23

Buy

48.58%

Upside

Reiterated

12/02/25

SI-Bone price target raised to $23 from $20 at Morgan StanleySI-Bone price target raised to $23 from $20 at Morgan Stanley

Travis Steed

Bank of America Securities

$23

Buy

48.58%

Upside

Reiterated

11/10/25

SI-Bone's Strong Financial Performance and Growth Prospects Justify Buy Rating

Ross Osborn

Cantor Fitzgerald

$25

Buy

61.50%

Upside

Reiterated

08/11/25

Cantor Fitzgerald Keeps Their Buy Rating on SI-Bone (SIBN)

David Turkaly

Citizens JMP

$32

Buy

106.72%

Upside

Reiterated

05/06/25

Citizens JMP Keeps Their Buy Rating on SI-Bone (SIBN)

Matthew O'Brien

Piper Sandler

$25

Buy

61.50%

Upside

Reiterated

02/25/25

Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (NASDAQ: MLYS) and SI-Bone (NASDAQ: SIBN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Mathew Blackman

TD Cowen

$21

Buy

35.66%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Molecular Partners (NASDAQ: MOLN) and SI-Bone (NASDAQ: SIBN)

Richard Newitter

Truist Financial

―

Buy

―

Reiterated

01/13/26

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (NASDAQ: BLTE), Sight Sciences (NASDAQ: SGHT) and SI-Bone (NASDAQ: SIBN)

William Plovanic

Canaccord Genuity

$27

Buy

74.42%

Upside

Reiterated

01/13/26

Canaccord Genuity Reaffirms Their Buy Rating on SI-Bone (SIBN)

David Saxon

Needham

$27

Buy

74.42%

Upside

Reiterated

01/12/26

Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY), SI-Bone (NASDAQ: SIBN) and Guardant Health (NASDAQ: GH)

Rong Li

Jefferies

Not Ranked

Jefferies

$28

Buy

80.88%

Upside

Reiterated

01/09/26

Jefferies Remains a Buy on SI-Bone (SIBN)

Patrick Wood

Morgan Stanley

$20→$23

Buy

48.58%

Upside

Reiterated

12/02/25

SI-Bone price target raised to $23 from $20 at Morgan StanleySI-Bone price target raised to $23 from $20 at Morgan Stanley

Travis Steed

Bank of America Securities

$23

Buy

48.58%

Upside

Reiterated

11/10/25

SI-Bone's Strong Financial Performance and Growth Prospects Justify Buy Rating

Ross Osborn

Cantor Fitzgerald

$25

Buy

61.50%

Upside

Reiterated

08/11/25

Cantor Fitzgerald Keeps Their Buy Rating on SI-Bone (SIBN)

David Turkaly

Citizens JMP

$32

Buy

106.72%

Upside

Reiterated

05/06/25

Citizens JMP Keeps Their Buy Rating on SI-Bone (SIBN)

Matthew O'Brien

Piper Sandler

$25

Buy

61.50%

Upside

Reiterated

02/25/25

Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (NASDAQ: MLYS) and SI-Bone (NASDAQ: SIBN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SI-Bone

3 Months

xxx

Success Rate

6/12 ratings generated profit

Average Return

+5.88%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.88% per trade.

1 Year

Richard NewitterTruist Financial

Success Rate

7/12 ratings generated profit

Average Return

+3.49%

reiterated a buy rating last month

Copying Richard Newitter's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +3.49% per trade.

2 Years

xxx

Success Rate

5/12 ratings generated profit

Average Return

-0.96%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -0.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SIBN Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SIBN has received 11 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. SIBN average Analyst price target in the past 3 months is 25.20.

Each month's total comprises the sum of three months' worth of ratings.

SIBN Financial Forecast

SIBN Earnings Forecast

Currently, no earnings data available.

SIBN Sales Forecast

Currently, no sales data available.

SIBN Stock Forecast FAQ

What is SIBN’s average 12-month price target, according to analysts?

Based on analyst ratings, SI-Bone Inc’s 12-month average price target is 25.20.

What is SIBN’s upside potential, based on the analysts’ average price target?

SI-Bone Inc has 62.79% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SIBN a Buy, Sell or Hold?

SI-Bone Inc has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is SI-Bone Inc’s price target?

The average price target for SI-Bone Inc is 25.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.00 ,the lowest forecast is $21.00. The average price target represents 62.79% Increase from the current price of $15.48.

What do analysts say about SI-Bone Inc?

SI-Bone Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of SIBN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

SI-Bone (SIBN) Stock Forecast & Price Target

SIBN Analyst Ratings

SIBN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering SI-Bone

SIBN Analyst Recommendation Trends

SIBN Financial Forecast

SIBN Earnings Forecast

SIBN Sales Forecast

SIBN Stock Forecast FAQ

Detailed List of Analyst Forecasts